glutathione treatment for neuropathy North Central Cancer Group/Alliance trial N08CA—the use of prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study - Leal - 2014 - Cancer PDF] Bortezomib-induced peripheral neuropathy in
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
![glutathione treatment for neuropathy North Central Cancer Group/Alliance trial N08CAthe use of prevention of paclitaxel/carboplatininduced peripheral neuropathy: A phase 3 randomized, doubleblind, placebocontrolled study - Leal - 2014 - Cancer PDF] Bortezomib-induced peripheral neuropathy in](https://figures.semanticscholar.org/bdc9c26bee5513c8b2aa29966618a8e836ec93e6/3-Figure1-1.png)
![glutathione treatment for neuropathy North Central Cancer Group/Alliance trial N08CAthe use of prevention of paclitaxel/carboplatininduced peripheral neuropathy: A phase 3 randomized, doubleblind, placebocontrolled study - Leal - 2014 - Cancer PDF] Bortezomib-induced peripheral neuropathy in](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcba/5375987/43c6f9bd6368/ajtr0009-0926-f6.jpg)
![glutathione treatment for neuropathy North Central Cancer Group/Alliance trial N08CAthe use of prevention of paclitaxel/carboplatininduced peripheral neuropathy: A phase 3 randomized, doubleblind, placebocontrolled study - Leal - 2014 - Cancer PDF] Bortezomib-induced peripheral neuropathy in](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-025-02175-1/MediaObjects/41392_2025_2175_Fig1_HTML.png)